SCHEMBL20021547

SCHEMBL20021547

OC[C@H](O)c1cc(F)ccc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.49
CES1 P23141 3/20 0.49
PSEN1 P49768 5/20 0.44
PSEN2 P49810 5/20 0.44
APH1B Q8WW43 5/20 0.44
NCSTN Q92542 5/20 0.44
APH1A Q96BI3 5/20 0.44
PSENEN Q9NZ42 5/20 0.44
ADRA2C P18825 3/20 0.43
ADRA2A P08913 2/20 0.43
ADRA2B P18089 2/20 0.43
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
ADRA1A P35348 2/20 0.38
ADRB2 P07550 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30446775 0.84 PSEN1 (0.49) CES2CES1PSEN1PSEN2APH1B
SCHEMBL31074203 0.84 PSEN1 (0.49) CES2CES1PSEN1PSEN2APH1B
SCHEMBL3199954 0.84 PSEN1 (0.49) CES2CES1PSEN1PSEN2APH1B
SCHEMBL23489620 0.83 CES2 (0.49) CES2CES1PSEN1PSEN2APH1B
SCHEMBL7149087 0.83 ADRA2C (0.57) CES2CES1ADRA2CADRA2AADRA2B
SCHEMBL12303658 0.83 CES2 (0.49) CES2CES1PSEN1PSEN2APH1B
SCHEMBL953919 0.82 PDE2A (0.50) CES2CES1PSEN1PSEN2APH1B
SCHEMBL28982124 0.80 CES2 (0.35) CES2CES1PSEN1PSEN2APH1B
SCHEMBL30295400 0.80 CES2 (0.35) CES2CES1PSEN1PSEN2APH1B
SCHEMBL21250530 0.79 CES2 (0.49) CES2CES1PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093992-A1 PROCESS FOR PREPARING CHIRAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS MERCK SHARP & DOHME LLC 2018-04-05 US disclosed
US-20180093992-A1 PROCESS FOR PREPARING CHIRAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS MERCK SHARP & DOHME LLC 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093992-A1 PROCESS FOR PREPARING CHIRAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS DPP4, PEPD, DPP9 CES2 1126/4885CES1 306/4885PSEN1 1506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.